Proton Pump Inhibitor;
Photodynamic Therapy;
Intestinal Metaplasia;
Main Drug Interaction;
Porfimer Sodium;
D O I:
10.1007/s11938-001-0048-9
中图分类号:
学科分类号:
摘要:
Dysplasia is the most important marker of progression to invasive cancer in Barrett’s esophagus.Intensive endoscopic surveillance with biopsy may identify invasive cancer in a patient with high-grade dysplasia (HGD).Close relationship with an experienced gastrointestinal pathologist and thoracic surgeon will improve treatment decisions and patient outcomes.No intervention is required in patients with low-grade dysplasia (LGD); continued surveillance is recommended.Surgical resection is the currently accepted therapy for high-grade dysplasia. Endoscopic ablative therapy remains experimental.
机构:
Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
Harvard Med Sch, Dept Pathol, 75 Francis St Cotran 3, Boston, MA 02115 USABrigham & Womens Hosp, Dept Pathol, Boston, MA USA
Patil, Deepa T.
Odze, Robert D.
论文数: 0引用数: 0
h-index: 0
机构:
Tufts Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA USABrigham & Womens Hosp, Dept Pathol, Boston, MA USA
机构:
Boston Univ, Sch Med, Gastroenterol & Hepatol Sect, VA Boston Healthcare Syst, Boston, MA 02118 USABoston Univ, Sch Med, Gastroenterol & Hepatol Sect, VA Boston Healthcare Syst, Boston, MA 02118 USA